To interrogate the role of CCL2 in anti-tumor NK cell responses in PDAC, we first engineered KPC PDAC cell lines to express a Ccl2 cDNA (or an Empty vector as a control) (Fig. 6c). The gene discussed is CCL2; the disease is neoplasm.